Your browser doesn't support javascript.
loading
CALHM1 P86L polymorphism modulates CSF Aß levels in cognitively healthy individuals at risk for Alzheimer's disease.
Koppel, Jeremy; Campagne, Fabien; Vingtdeux, Valérie; Dreses-Werringloer, Ute; Ewers, Michael; Rujescu, Dan; Hampel, Harald; Gordon, Marc L; Christen, Erica; Chapuis, Julien; Greenwald, Blaine S; Davies, Peter; Marambaud, Philippe.
Affiliation
  • Koppel J; Litwin-Zucker Research Center for the Study of Alzheimer's Disease, The Feinstein Institute for Medical Research, Manhasset, New York, USA.
Mol Med ; 17(9-10): 974-9, 2011.
Article in En | MEDLINE | ID: mdl-21629967
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Membrane Glycoproteins / Calcium Channels / Amyloid beta-Peptides / Polymorphism, Single Nucleotide / Alzheimer Disease Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Mol Med Journal subject: BIOLOGIA MOLECULAR Year: 2011 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Membrane Glycoproteins / Calcium Channels / Amyloid beta-Peptides / Polymorphism, Single Nucleotide / Alzheimer Disease Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Mol Med Journal subject: BIOLOGIA MOLECULAR Year: 2011 Type: Article Affiliation country: United States